BioGenerator Ventures
Overview
BioGenerator Ventures is a venture capital firm and the investment arm of BioSTL that creates, builds, and invests in early-stage companies solving problems in human health and agriculture. The firm invests in the therapeutics, diagnostics, medical devices, research tools, and agtech sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| MediBeacon | Aug 2015 | VC Round | Co-investor |
| Equator Therapeutics | - | VC Round | Co-investor |
| Euclises Pharmaceuticals | Apr 2015 | Series A Extension | Co-investor |
| Bond Biosciences | Mar 2021 | Series A | Co-investor |
| INTENT, INC. | Aug 2023 | Series A | Lead |
For institutional investors. Book with your work email.
Key People
Allyson Mayer
Principal
Mark Lewis
Venture Capital Fellow
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BioGenerator Ventures based?
BioGenerator Ventures is headquartered in Saint Louis, Michigan, United States.
When was BioGenerator Ventures founded?
BioGenerator Ventures was founded in 2003.
How many portfolio companies does BioGenerator Ventures have?
BioGenerator Ventures has 41 portfolio companies in Caplight's dataset.
What are some companies in BioGenerator Ventures's portfolio?
Portfolio companies visible on Caplight include MediBeacon, Equator Therapeutics, Euclises Pharmaceuticals, Bond Biosciences, INTENT, INC..
What was BioGenerator Ventures's most recent investment shown here?
BioGenerator Ventures's most recent investment in this portfolio sample was in INTENT, INC. in 2023.
What sectors does BioGenerator Ventures focus on?
BioGenerator Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Consumer & Commerce, Energy & Sustainability, Energy & Sustainability, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does BioGenerator Ventures focus on?
BioGenerator Ventures typically invests at the Early stage.
What is BioGenerator Ventures's AUM?
BioGenerator Ventures's assets under management are estimated between $50.0M and $100.0M.